We conclude that RARRES2, identified through our in-vitro circuit approach, mediates CAF signaling to TAMs in mouse models of breast cancer and in human disease, and may serve as a therapeutic target for future exploration. This evidence concerns the gene RARRES2 and breast carcinoma.